Non-Antibody Products — page 80 of 95
Non-Antibody Products
Page 80 of 95
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Avoralstat | s = 1.14-11.1 nM); inhibits TMPRSS2 (IC50 = 2.73 nM); in… | 25 mg | 35610-25 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Avoralstat | s = 1.14-11.1 nM); inhibits TMPRSS2 (IC50 = 2.73 nM); in… | 5 mg | 35610-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACSF2 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93920-V |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Jun8-76-3A | Jun8-76-3A is a potent and selective noncovalent SARS-CoV-2
| 1 g |
orb1909978 |
|
 BIORBYT LTD.
More Info
|
|
| SFKEELDKYFKNHTSP | Epitope from the S2 Protein of SARS-CoV-2. Puri… | 1 mg | orb1140628 |
BIORBYT LTD. |
More Info |
| Anti-SARS-Cov-2 ELISA IgG | This Anti-SARS-CoV-2 ELISA (IgG) kit has been designed f… | 1 kit | ATGCF001 |
 NKMAX Co. Ltd. |
More Info |
| ACSS2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-140835-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| MCCB shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-60999-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N), partial | -PAGE. Host: E. coli. Species: Severe acute respiratory syndrome coronavir… | , 100ug, 1mg | RPC27926 |
 BIOMATIK |
More Info |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S), partial | . Species: Severe acute respiratory syndrome coronavirus 2 (2019-… | 20ug, 100ug, 1mg | RPC27928 |
BIOMATIK |
More Info |
| Recombinant Severe acute respiratory syndrome coronavirus 2 3C-like proteinase (NSP5) | : Severe acute respiratory syndrome coronavirus 2 (2019-nCoV<… | 20ug, 100ug, 1mg | RPC27940 |
BIOMATIK |
More Info |
| SMRTe shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-36515-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| MSG606 (trifluoroacetate salt) | .5 µg / animal, i.c.v.; reduces protein levels of merlin in… | 1 mg | 41550-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MSG606 (trifluoroacetate salt) | .5 µg / animal, i.c.v.; reduces protein levels of merlin in… | 10 mg | 41550-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MSG606 (trifluoroacetate salt) | .5 µg / animal, i.c.v.; reduces protein levels of merlin in… | 5 mg | 41550-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MSG606 (trifluoroacetate salt) | .5 µg / animal, i.c.v.; reduces protein levels of merlin in… | 500 µg | 41550-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| DECR2 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93455-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ATN-161 (trifluoroacetate salt) | and human ACE2 or SARS-CoV-2 spike protein in… | 1 mg | 34056-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ATN-161 (trifluoroacetate salt) | and human ACE2 or SARS-CoV-2 spike protein in… | 10 mg | 34056-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ATN-161 (trifluoroacetate salt) | and human ACE2 or SARS-CoV-2 spike protein in… | 25 mg | 34056-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ATN-161 (trifluoroacetate salt) | and human ACE2 or SARS-CoV-2 spike protein in… | 5 mg | 34056-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SCOT-t shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-153267-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| LPCAT2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-149021-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ACOT1/2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-72434-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ACSM2B shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93493-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Masitinib | Δ27 (IC50s = 3 and 5 nM, respectively); an inhibitor of SARS-CoV… | 10 mg | 13105-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Masitinib | Δ27 (IC50s = 3 and 5 nM, respectively); an inhibitor of SARS-CoV… | 100 mg | 13105-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Masitinib | Δ27 (IC50s = 3 and 5 nM, respectively); an inhibitor of SARS-CoV… | 25 mg | 13105-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Masitinib | Δ27 (IC50s = 3 and 5 nM, respectively); an inhibitor of SARS-CoV… | 50 mg | 13105-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| HACL1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-78507-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S) (D614G), partial | syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-<… | 20ug, 100ug, 1mg | RPC28792 |
BIOMATIK |
More Info |
| Bisoprolol (hemifumarate) | .5 mg / kg twice per day over 19 weeks; inhibits SARS-CoV-2
| 100 mg |
23827-100 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Bisoprolol (hemifumarate) | .5 mg / kg twice per day over 19 weeks; inhibits SARS-CoV-2
| 250 mg |
23827-250 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Bisoprolol (hemifumarate) | .5 mg / kg twice per day over 19 weeks; inhibits SARS-CoV-2
| 50 mg |
23827-50 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Anti-GD2 (31F9V2) h(scFv-CD3ε) TRuC-Jurkat Cells | the absence of an extra co-stimulatory domain. | n/a | XS-0123-ZP1093 |
 CREATIVE BIOLABS, INC. |
More Info |
| Anti-GD2 (31F9V2) h(scFv-CD3ε) TRuC-Jurkat Cells | the absence of an extra co-stimulatory domain. | n/a | XS-0123-ZP1093 |
CREATIVE BIOLABS, INC. |
More Info |
| LPCAT2 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93397-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| LEGENDplex™ COVID-19 Cytokine Storm Panel 2 (12-plex) w/ FP | (SARS-CoV-2), has spread rapidly across the world to be… | 100 tests | 741141 |
 BIOLEGEND |
More Info |
| LEGENDplex™ COVID-19 Cytokine Storm Panel 2 (13-plex) w/ FP | (SARS-CoV-2), has spread rapidly across the world to be… | 100 tests | 741111 |
BIOLEGEND |
More Info |
| LEGENDplex™ COVID-19 Cytokine Storm Panel 2 (1-plex) w/ FP | (SARS-CoV-2), has spread rapidly across the world to be… | 100 tests | 741143 |
BIOLEGEND |
More Info |
| PECI shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-76104-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Hydroxychloroquine (sulfate) | individuals or patients with SLE or RA; inhibits accumulation of SQSTM1 p… | 100 mg | 17911-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Hydroxychloroquine (sulfate) | individuals or patients with SLE or RA; inhibits accumulation of SQSTM1 p… | 25 mg | 17911-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Hydroxychloroquine (sulfate) | individuals or patients with SLE or RA; inhibits accumulation of SQSTM1 p… | 250 mg | 17911-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Hydroxychloroquine (sulfate) | individuals or patients with SLE or RA; inhibits accumulation of SQSTM1 p… | 50 mg | 17911-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Mouse Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer Protein, His Tag&Tag Free (MALS verified) | &Tag Free, produced by co-expression of ITGAV and ITGB6, has a ca… | 100ug | IT6-M52W9-100ug |
 ACROBIOSYSTEMS USA |
More Info |
| Mouse Integrin alpha V beta 6 (ITGAV&ITGB6) Heterodimer Protein, His Tag&Tag Free (MALS verified) | &Tag Free, produced by co-expression of ITGAV and ITGB6, has a ca… | 1mg | IT6-M52W9-1mg |
ACROBIOSYSTEMS USA |
More Info |
| ACAA2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-140789-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 3 (nsp3 | -PAGE. Host: E. coli. Species: Severe acute respiratory syndrome coronavir… | 20ug, 100ug, 1mg | RPC27939 |
BIOMATIK |
More Info |
| Ensitrelvir (S-217622) | S-217622 is the first oral non-covalent, non-peptidic SARS-CoV-| 100 mg, 1 g, 250 mg, 10 mM * 1 mL in DMSO |
orb1473053 |
|
BIORBYT LTD.
More Info
|
|